National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting, 83953 [2023-26450]

Download as PDF 83953 Federal Register / Vol. 88, No. 230 / Friday, December 1, 2023 / Notices In compliance with section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, NIH has submitted to OMB a request for review and approval of the information collection listed below. Proposed Collection Title: Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report, OMB #0925–0765, expiration date 11/30/ 2022, Reinstatement with Change, Office of the Director (OD), National Institutes of Health (NIH). Need and Use of Information Collection: The NIH Office of Laboratory Welfare (OLAW) is responsible for the implementation, general administration, and interpretation of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (Policy) as codified in 42 CFR 52.8. The PHS Policy implements the Health Research Extension Act (HREA) of 1985 (Pub. L. 99–158 as codified in 42 U.S.C. 289d). The PHS Policy requires entities that conduct research involving vertebrate animals using PHS funds to have an Institutional Animal Care and Use Committee (IACUC), provide assurance that requirements of the Policy are met, and submit an annual report. Institutions in foreign countries comply with the PHS Policy or provide evidence that acceptable standards for the humane care and use of the animals in PHS-conducted or -supported activities will be met. An institution’s animal care and use program is described in the Animal Welfare Assurance (Assurance) document and sets forth institutional compliance with PHS Policy. The purpose of the Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report is to provide OLAW with documentation to satisfy the requirements of the HREA, illustrate institutional adherence to PHS Policy, and enable OLAW to carry out its mission to ensure the humane care and use of animals in PHS-supported research, testing, and training, thereby contributing to the quality of PHSsupported activities. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 9,219. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Average burden per response (in hours) Total annual burden hours Type of respondents Domestic Assurance ................................................................................... Domestic Annual Report ............................................................................. Foreign Assurance ...................................................................................... Foreign Annual Report ............................................................................... Interinstitutional Assurance for Foreign Performance Site or Interinstitutional Assurance Triad for Foreign Performance Site. Interinstitutional Assurance for Domestic Performance Site or Interinstitutional Assurance Triad for Domestic Performance Site. Renewal and New ....... All Domestic ................. Renewal and New ....... All Foreign .................... Foreign ......................... 235 890 67 335 46 1 1 1 1 1 30 90/60 90/60 1 30/60 7,050 1,335 101 335 23 Domestic ...................... 750 1 30/60 375 Total ..................................................................................................... ...................................... 2,323 6 .................... 9,219 Dated: November 22, 2023. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2023–26400 Filed 11–30–23; 8:45 am] BILLING CODE 4140–01–P location will stay the same. The meeting is closed to the public. Dated: November 27, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–26451 Filed 11–30–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSK11XQN23PROD with NOTICES1 Number of responses per respondent Form name BILLING CODE 4140–01–P National Institutes of Health National Cancer Institute; Amended Notice of Meeting National Institutes of Health Notice is hereby given of a change in the meeting of the National Cancer Institute Initial Review Group; Career Development Study Section (J), February 28, 2024, 10:00 a.m. to February 29, 2024, 06:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850 which was published in the Federal Register on November 2, 2023, FR Doc. 2023–24225, 88 FR 75294. This notice is being amended to change the start time of the meeting from 10:00 a.m. to 9:00 a.m. on February 28, 2024. The meeting dates and 18:47 Nov 30, 2023 Jkt 262001 Dated: November 28, 2023. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–26450 Filed 11–30–23; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 meeting to December 14, 2023, and December 15, 2023. The meeting time remains the same. The meeting is closed to the public. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, November 27, 2023, 10:00 a.m. to November 28, 2023, 05:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on November 13, 2023, FR Doc 2023– 24961, 88 FR 77597. This notice is being amended to change the dates of this two-day PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities SUMMARY: E:\FR\FM\01DEN1.SGM 01DEN1

Agencies

[Federal Register Volume 88, Number 230 (Friday, December 1, 2023)]
[Notices]
[Page 83953]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26450]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Neurological Disorders and Stroke Special Emphasis Panel, 
November 27, 2023, 10:00 a.m. to November 28, 2023, 05:00 p.m., 
National Institutes of Health, Neuroscience Center, 6001 Executive 
Boulevard, Rockville, MD 20852 which was published in the Federal 
Register on November 13, 2023, FR Doc 2023-24961, 88 FR 77597.
    This notice is being amended to change the dates of this two-day 
meeting to December 14, 2023, and December 15, 2023. The meeting time 
remains the same. The meeting is closed to the public.

    Dated: November 28, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2023-26450 Filed 11-30-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.